Frequencies for first 10,000 rows of indi_pt variable in indi2012q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 4 0.04 0.04 ABDOMINAL DISTENSION | 2 0.02 0.06 ABDOMINAL PAIN | 10 0.10 0.16 ABDOMINAL PAIN UPPER | 8 0.08 0.24 ABDOMINAL SYMPTOM | 1 0.01 0.25 ABNORMAL BEHAVIOUR | 4 0.04 0.29 ABNORMAL FAECES | 4 0.04 0.33 ACNE | 40 0.40 0.73 ACNE CYSTIC | 3 0.03 0.76 ACROMEGALY | 6 0.06 0.82 ACUTE CORONARY SYNDROME | 7 0.07 0.89 ACUTE GRAFT VERSUS HOST DISEASE | 3 0.03 0.92 ACUTE LYMPHOCYTIC LEUKAEMIA | 6 0.06 0.98 ACUTE MYELOID LEUKAEMIA | 25 0.25 1.23 ACUTE MYELOMONOCYTIC LEUKAEMIA | 1 0.01 1.24 ACUTE RESPIRATORY FAILURE | 1 0.01 1.25 ACUTE TONSILLITIS | 1 0.01 1.26 ADENOCARCINOMA PANCREAS | 5 0.05 1.31 ADENOSQUAMOUS CELL LUNG CANCER STAGE IV | 1 0.01 1.32 ADJUSTMENT DISORDER | 2 0.02 1.34 ADRENAL INSUFFICIENCY | 2 0.02 1.36 ADVERSE DRUG REACTION | 1 0.01 1.37 AFFECTIVE DISORDER | 11 0.11 1.48 AGE-RELATED MACULAR DEGENERATION | 7 0.07 1.55 AGGRESSION | 1 0.01 1.56 AGITATED DEPRESSION | 1 0.01 1.57 AGITATION | 7 0.07 1.64 AGORAPHOBIA | 1 0.01 1.65 ALCOHOL REHABILITATION | 3 0.03 1.68 ALCOHOL WITHDRAWAL SYNDROME | 2 0.02 1.70 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 5 0.05 1.75 ALOPECIA | 15 0.15 1.90 ALPHA-1 ANTI-TRYPSIN DEFICIENCY | 1 0.01 1.91 AMNESIA | 2 0.02 1.93 AMYLOIDOSIS | 1 0.01 1.94 ANAEMIA | 18 0.18 2.12 ANAEMIA PROPHYLAXIS | 1 0.01 2.13 ANAESTHESIA | 21 0.21 2.34 ANAESTHESIA PROCEDURE | 22 0.22 2.56 ANAL FISSURE | 1 0.01 2.57 ANALGESIC THERAPY | 36 0.36 2.93 ANAPHYLACTIC REACTION | 2 0.02 2.95 ANDROGENETIC ALOPECIA | 4 0.04 2.99 ANGINA PECTORIS | 10 0.10 3.09 ANGIODYSPLASIA | 1 0.01 3.10 ANGIOEDEMA | 1 0.01 3.11 ANGIOGRAM | 11 0.11 3.22 ANGIOSARCOMA METASTATIC | 2 0.02 3.24 ANKYLOSING SPONDYLITIS | 19 0.19 3.43 ANTI-INFECTIVE THERAPY | 1 0.01 3.44 ANTIBIOTIC PROPHYLAXIS | 6 0.06 3.50 ANTIBIOTIC THERAPY | 1 0.01 3.51 ANTICOAGULANT THERAPY | 19 0.19 3.70 ANTIDEPRESSANT THERAPY | 5 0.05 3.75 ANTIEMETIC SUPPORTIVE CARE | 3 0.03 3.78 ANTIFUNGAL PROPHYLAXIS | 5 0.05 3.83 ANTIINFLAMMATORY THERAPY | 3 0.03 3.86 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 3.87 ANTIPLATELET THERAPY | 7 0.07 3.94 ANTIPYRESIS | 1 0.01 3.95 ANTIRETROVIRAL THERAPY | 13 0.13 4.08 ANTIVIRAL PROPHYLAXIS | 4 0.04 4.12 ANTIVIRAL TREATMENT | 3 0.03 4.15 ANXIETY | 80 0.80 4.95 AORTIC ANEURYSM | 1 0.01 4.96 AORTIC VALVE INCOMPETENCE | 1 0.01 4.97 APLASTIC ANAEMIA | 16 0.16 5.13 ARRHYTHMIA | 22 0.22 5.35 ARTERIAL DISORDER | 2 0.02 5.37 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 5.38 ARTHRALGIA | 9 0.09 5.47 ARTHRITIS | 27 0.27 5.74 ARTHROPOD BITE | 1 0.01 5.75 ASCITES | 2 0.02 5.77 ASPERGILLOSIS | 3 0.03 5.80 ASPIRATION BONE MARROW | 1 0.01 5.81 ASTHENIA | 1 0.01 5.82 ASTHMA | 116 1.16 6.98 ATRIAL FIBRILLATION | 96 0.96 7.94 ATRIAL SEPTAL DEFECT | 1 0.01 7.95 ATRIAL TACHYCARDIA | 2 0.02 7.97 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 22 0.22 8.19 AUTISM | 3 0.03 8.22 AUTOIMMUNE DISORDER | 3 0.03 8.25 AUTOIMMUNE THYROIDITIS | 1 0.01 8.26 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 8.27 B PRECURSOR TYPE ACUTE LEUKAEMIA | 12 0.12 8.39 B-CELL LYMPHOMA | 9 0.09 8.48 BACK DISORDER | 2 0.02 8.50 BACK INJURY | 2 0.02 8.52 BACK PAIN | 48 0.48 9.00 BACTERIAL INFECTION | 3 0.03 9.03 BARRETT'S OESOPHAGUS | 1 0.01 9.04 BEHAVIOURAL AND PSYCHIATRIC SYMPTOMS .. | 1 0.01 9.05 BEHCET'S SYNDROME | 6 0.06 9.11 BENIGN PROSTATIC HYPERPLASIA | 10 0.10 9.21 BILE DUCT CANCER | 10 0.10 9.31 BINGE DRINKING | 3 0.03 9.34 BIPOLAR DISORDER | 42 0.42 9.76 BIPOLAR I DISORDER | 13 0.13 9.89 BLADDER CANCER | 3 0.03 9.92 BLADDER DISORDER | 4 0.04 9.96 BLADDER DYSFUNCTION | 2 0.02 9.98 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 9.99 BLASTOMYCOSIS | 8 0.08 10.07 BLOOD CHOLESTEROL | 30 0.30 10.37 BLOOD CHOLESTEROL ABNORMAL | 24 0.24 10.61 BLOOD CHOLESTEROL INCREASED | 49 0.49 11.10 BLOOD CORTICOTROPHIN DECREASED | 2 0.02 11.12 BLOOD DISORDER | 2 0.02 11.14 BLOOD FOLLICLE STIMULATING HORMONE DE.. | 1 0.01 11.15 BLOOD GLUCOSE | 1 0.01 11.16 BLOOD GLUCOSE ABNORMAL | 1 0.01 11.17 BLOOD GLUCOSE INCREASED | 1 0.01 11.18 BLOOD IRON | 1 0.01 11.19 BLOOD IRON DECREASED | 1 0.01 11.20 BLOOD LUTEINISING HORMONE DECREASED | 1 0.01 11.21 BLOOD OESTROGEN DECREASED | 1 0.01 11.22 BLOOD POTASSIUM | 1 0.01 11.23 BLOOD POTASSIUM DECREASED | 2 0.02 11.25 BLOOD PRESSURE | 41 0.41 11.66 BLOOD PRESSURE ABNORMAL | 23 0.23 11.89 BLOOD PRESSURE DECREASED | 4 0.04 11.93 BLOOD PRESSURE INCREASED | 4 0.04 11.97 BLOOD PRESSURE MANAGEMENT | 2 0.02 11.99 BLOOD SODIUM DECREASED | 2 0.02 12.01 BLOOD TESTOSTERONE | 1 0.01 12.02 BLOOD TESTOSTERONE DECREASED | 4 0.04 12.06 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 12.07 BLOOD TRIGLYCERIDES | 1 0.01 12.08 BLOOD TRIGLYCERIDES INCREASED | 2 0.02 12.10 BLOOD URIC ACID | 1 0.01 12.11 BODY HEIGHT BELOW NORMAL | 5 0.05 12.16 BONE DENSITY ABNORMAL | 1 0.01 12.17 BONE DENSITY DECREASED | 1 0.01 12.18 BONE DISORDER | 8 0.08 12.26 BONE ELECTROSTIMULATION THERAPY | 1 0.01 12.27 BONE GIANT CELL TUMOUR | 2 0.02 12.29 BONE LESION | 3 0.03 12.32 BONE LOSS | 3 0.03 12.35 BONE MARROW CONDITIONING REGIMEN | 15 0.15 12.50 BONE PAIN | 1 0.01 12.51 BOWEL MOVEMENT IRREGULARITY | 1 0.01 12.52 BRAIN OPERATION | 2 0.02 12.54 BREAKTHROUGH PAIN | 3 0.03 12.57 BREAST CANCER | 46 0.46 13.03 BREAST CANCER FEMALE | 1 0.01 13.04 BREAST CANCER METASTATIC | 41 0.41 13.45 BREAST CANCER RECURRENT | 1 0.01 13.46 BREAST CYST | 1 0.01 13.47 BREAST NEOPLASM | 1 0.01 13.48 BREAST OPERATION | 1 0.01 13.49 BRONCHIAL CARCINOMA | 2 0.02 13.51 BRONCHIAL DISORDER | 1 0.01 13.52 BRONCHIAL OBSTRUCTION | 1 0.01 13.53 BRONCHITIS | 10 0.10 13.63 BRONCHITIS CHRONIC | 8 0.08 13.71 BRONCHOPULMONARY ASPERGILLOSIS | 4 0.04 13.75 BRONCHOPULMONARY DYSPLASIA | 1 0.01 13.76 BUDD-CHIARI SYNDROME | 1 0.01 13.77 C-REACTIVE PROTEIN INCREASED | 1 0.01 13.78 CANCER PAIN | 13 0.13 13.91 CANDIDA OSTEOMYELITIS | 1 0.01 13.92 CANDIDA TEST POSITIVE | 1 0.01 13.93 CANDIDIASIS | 2 0.02 13.95 CARCINOID SYNDROME | 1 0.01 13.96 CARCINOID TUMOUR | 6 0.06 14.02 CARCINOID TUMOUR PULMONARY | 1 0.01 14.03 CARDIAC ASTHMA | 1 0.01 14.04 CARDIAC DISORDER | 55 0.55 14.59 CARDIAC ENZYMES | 1 0.01 14.60 CARDIAC FAILURE | 18 0.18 14.78 CARDIAC FAILURE ACUTE | 1 0.01 14.79 CARDIAC FAILURE CHRONIC | 14 0.14 14.93 CARDIAC FAILURE CONGESTIVE | 9 0.09 15.02 CARDIAC OPERATION | 1 0.01 15.03 CARDIAC REHABILITATION THERAPY | 1 0.01 15.04 CARDIOMYOPATHY | 4 0.04 15.08 CARDIOVASCULAR DISORDER | 4 0.04 15.12 CARDIOVASCULAR EVENT PROPHYLAXIS | 9 0.09 15.21 CARPAL TUNNEL SYNDROME | 2 0.02 15.23 CATAPLEXY | 2 0.02 15.25 CATARACT | 1 0.01 15.26 CATHETERISATION CARDIAC | 1 0.01 15.27 CELLULITIS | 2 0.02 15.29 CENTRAL VENOUS CATHETERISATION | 1 0.01 15.30 CEREBRAL INFARCTION | 3 0.03 15.33 CEREBRAL PALSY | 2 0.02 15.35 CEREBROVASCULAR ACCIDENT | 4 0.04 15.39 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 20 0.20 15.59 CERVICAL VERTEBRAL FRACTURE | 2 0.02 15.61 CHEMOTHERAPY | 5 0.05 15.66 CHEST DISCOMFORT | 3 0.03 15.69 CHEST PAIN | 2 0.02 15.71 CHOLANGITIS | 5 0.05 15.76 CHRONIC FATIGUE SYNDROME | 2 0.02 15.78 CHRONIC HEPATITIS | 1 0.01 15.79 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 15.80 CHRONIC LYMPHOCYTIC LEUKAEMIA | 27 0.27 16.07 CHRONIC MYELOID LEUKAEMIA | 32 0.32 16.39 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 104 1.04 17.43 CIRCADIAN RHYTHM SLEEP DISORDER | 7 0.07 17.50 CLAUSTROPHOBIA | 1 0.01 17.51 COAGULOPATHY | 2 0.02 17.53 COGNITIVE DISORDER | 3 0.03 17.56 COLITIS | 5 0.05 17.61 COLITIS MICROSCOPIC | 1 0.01 17.62 COLITIS ULCERATIVE | 62 0.62 18.24 COLON CANCER | 20 0.20 18.44 COLON CANCER METASTATIC | 13 0.13 18.57 COLORECTAL CANCER | 25 0.25 18.82 COLORECTAL CANCER METASTATIC | 13 0.13 18.95 COMPLEX REGIONAL PAIN SYNDROME | 6 0.06 19.01 COMPUTERISED TOMOGRAM | 2 0.02 19.03 CONJUNCTIVITIS | 1 0.01 19.04 CONJUNCTIVITIS ALLERGIC | 5 0.05 19.09 CONNECTIVE TISSUE DISORDER | 3 0.03 19.12 CONSTIPATION | 49 0.49 19.61 CONTRACEPTION | 121 1.21 20.82 CONVULSION | 38 0.38 21.20 CONVULSION PROPHYLAXIS | 1 0.01 21.21 CORNEAL DISORDER | 2 0.02 21.23 CORONARY ANGIOPLASTY | 1 0.01 21.24 CORONARY ARTERIAL STENT INSERTION | 1 0.01 21.25 CORONARY ARTERY BYPASS | 2 0.02 21.27 CORONARY ARTERY DISEASE | 9 0.09 21.36 COSTOCHONDRITIS | 1 0.01 21.37 COUGH | 5 0.05 21.42 CROHN'S DISEASE | 122 1.22 22.64 CRUSH INJURY | 1 0.01 22.65 CRYPTOCOCCOSIS | 1 0.01 22.66 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 22.67 CYSTIC FIBROSIS | 2 0.02 22.69 CYSTITIS HAEMORRHAGIC | 1 0.01 22.70 CYSTITIS INTERSTITIAL | 2 0.02 22.72 CYTARABINE SYNDROME | 1 0.01 22.73 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 22.74 DANDRUFF | 1 0.01 22.75 DECREASED APPETITE | 4 0.04 22.79 DECUBITUS ULCER | 1 0.01 22.80 DEEP VEIN THROMBOSIS | 6 0.06 22.86 DEHYDRATION | 2 0.02 22.88 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 22.89 DEMENTIA | 13 0.13 23.02 DEMENTIA ALZHEIMER'S TYPE | 24 0.24 23.26 DEMYELINATION | 1 0.01 23.27 DEPRESSED MOOD | 4 0.04 23.31 DEPRESSION | 161 1.61 24.92 DEPRESSIVE SYMPTOM | 1 0.01 24.93 DERMATITIS | 1 0.01 24.94 DERMATITIS ATOPIC | 2 0.02 24.96 DERMATOMYOSITIS | 2 0.02 24.98 DERMATOSIS | 2 0.02 25.00 DEVICE RELATED INFECTION | 2 0.02 25.02 DIABETES MELLITUS | 123 1.23 26.25 DIABETES MELLITUS INADEQUATE CONTROL | 1 0.01 26.26 DIABETIC NEUROPATHY | 6 0.06 26.32 DIABETIC RETINAL OEDEMA | 2 0.02 26.34 DIALYSIS | 2 0.02 26.36 DIARRHOEA | 11 0.11 26.47 DIFFUSE LARGE B-CELL LYMPHOMA | 50 0.50 26.97 DISTURBANCE IN ATTENTION | 1 0.01 26.98 DIURETIC THERAPY | 9 0.09 27.07 DIVERTICULITIS | 1 0.01 27.08 DIZZINESS | 3 0.03 27.11 DRUG ABUSE | 5 0.05 27.16 DRUG DEPENDENCE | 1 0.01 27.17 DRUG ERUPTION | 3 0.03 27.20 DRUG WITHDRAWAL MAINTENANCE THERAPY | 1 0.01 27.21 DRUG WITHDRAWAL SYNDROME | 1 0.01 27.22 DRY EYE | 2 0.02 27.24 DRY MOUTH | 1 0.01 27.25 DRY SKIN | 1 0.01 27.26 DUODENAL ULCER | 3 0.03 27.29 DYSAESTHESIA | 1 0.01 27.30 DYSLIPIDAEMIA | 10 0.10 27.40 DYSMENORRHOEA | 16 0.16 27.56 DYSPEPSIA | 28 0.28 27.84 DYSPHAGIA | 2 0.02 27.86 DYSPNOEA | 16 0.16 28.02 EAR INFECTION | 3 0.03 28.05 EATING DISORDER | 1 0.01 28.06 ECZEMA | 4 0.04 28.10 ELECTROLYTE SUBSTITUTION THERAPY | 4 0.04 28.14 EMBOLIC STROKE | 1 0.01 28.15 EMBOLISM VENOUS | 3 0.03 28.18 EMOTIONAL DISORDER | 1 0.01 28.19 EMOTIONAL DISTRESS | 2 0.02 28.21 ENDOMETRIAL CANCER | 3 0.03 28.24 ENDOMETRIOSIS | 2 0.02 28.26 ENTEROCOLITIS BACTERIAL | 3 0.03 28.29 EPILEPSY | 40 0.40 28.69 ERECTILE DYSFUNCTION | 15 0.15 28.84 ERYSIPELAS | 2 0.02 28.86 ERYTHRODERMIC PSORIASIS | 1 0.01 28.87 ESSENTIAL HYPERTENSION | 9 0.09 28.96 ESSENTIAL THROMBOCYTHAEMIA | 6 0.06 29.02 EUTHYROID SICK SYNDROME | 1 0.01 29.03 EX-TOBACCO USER | 3 0.03 29.06 EXOMPHALOS | 1 0.01 29.07 EXOSTOSIS | 1 0.01 29.08 EXPOSURE DURING BREAST FEEDING | 2 0.02 29.10 EXPOSURE VIA SEMEN | 1 0.01 29.11 EXTRAPYRAMIDAL DISORDER | 4 0.04 29.15 EYE DISORDER | 1 0.01 29.16 EYE INJURY | 1 0.01 29.17 EYE IRRITATION | 2 0.02 29.19 EYE PAIN | 3 0.03 29.22 FACIAL PAIN | 2 0.02 29.24 FACIAL SPASM | 1 0.01 29.25 FACTOR V LEIDEN MUTATION | 1 0.01 29.26 FACTOR VIII DEFICIENCY | 2 0.02 29.28 FACTOR VIII INHIBITION | 2 0.02 29.30 FAECES HARD | 1 0.01 29.31 FALLOPIAN TUBE CANCER STAGE III | 2 0.02 29.33 FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIO.. | 3 0.03 29.36 FATIGUE | 28 0.28 29.64 FEBRILE NEUTROPENIA | 8 0.08 29.72 FEMALE STERILISATION | 1 0.01 29.73 FEMORAL NECK FRACTURE | 1 0.01 29.74 FIBROMYALGIA | 29 0.29 30.03 FLATULENCE | 1 0.01 30.04 FLUID RETENTION | 11 0.11 30.15 FOETAL EXPOSURE DURING PREGNANCY | 3 0.03 30.18 FOLATE DEFICIENCY | 1 0.01 30.19 FRACTURE | 1 0.01 30.20 FUNGAL INFECTION | 4 0.04 30.24 FUNGAL SKIN INFECTION | 1 0.01 30.25 GAIT DISTURBANCE | 3 0.03 30.28 GASTRECTOMY | 1 0.01 30.29 GASTRIC CANCER STAGE III | 6 0.06 30.35 GASTRIC DISORDER | 5 0.05 30.40 GASTRIC ULCER | 9 0.09 30.49 GASTRITIS | 30 0.30 30.79 GASTRITIS PROPHYLAXIS | 3 0.03 30.82 GASTROENTERITIS | 1 0.01 30.83 GASTROINTESTINAL DISORDER | 6 0.06 30.89 GASTROINTESTINAL DISORDER THERAPY | 2 0.02 30.91 GASTROINTESTINAL HAEMORRHAGE | 9 0.09 31.00 GASTROINTESTINAL PAIN | 2 0.02 31.02 GASTROINTESTINAL STROMAL TUMOUR | 10 0.10 31.12 GASTROOESOPHAGEAL REFLUX DISEASE | 103 1.03 32.15 GAUCHER'S DISEASE | 2 0.02 32.17 GENERAL ANAESTHESIA | 1 0.01 32.18 GENERALISED NON-CONVULSIVE EPILEPSY | 2 0.02 32.20 GLAUCOMA | 9 0.09 32.29 GLIOBLASTOMA | 6 0.06 32.35 GLIOMA | 2 0.02 32.37 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 32.38 GLYCOGEN STORAGE DISEASE TYPE II | 2 0.02 32.40 GOUT | 9 0.09 32.49 GOUTY ARTHRITIS | 1 0.01 32.50 GOUTY TOPHUS | 1 0.01 32.51 GRAFT VERSUS HOST DISEASE | 11 0.11 32.62 GRAFT VERSUS HOST DISEASE IN INTESTINE | 1 0.01 32.63 GRAND MAL CONVULSION | 4 0.04 32.67 GRANULOMA | 1 0.01 32.68 GROWTH HORMONE DEFICIENCY | 4 0.04 32.72 GROWTH RETARDATION | 1 0.01 32.73 GUILLAIN-BARRE SYNDROME | 1 0.01 32.74 HAEMATOMA | 1 0.01 32.75 HAEMOLYTIC URAEMIC SYNDROME | 2 0.02 32.77 HAEMORRHAGE | 1 0.01 32.78 HAEMORRHOIDS | 1 0.01 32.79 HAEMOSTASIS | 1 0.01 32.80 HAIRY CELL LEUKAEMIA | 1 0.01 32.81 HALLUCINATION | 1 0.01 32.82 HALLUCINATION, AUDITORY | 1 0.01 32.83 HEAD AND NECK CANCER | 19 0.19 33.02 HEAD INJURY | 1 0.01 33.03 HEADACHE | 31 0.31 33.34 HEART DISEASE CONGENITAL | 1 0.01 33.35 HEART RATE | 2 0.02 33.37 HEART RATE DECREASED | 1 0.01 33.38 HEART RATE INCREASED | 3 0.03 33.41 HEART RATE IRREGULAR | 5 0.05 33.46 HEART VALVE REPLACEMENT | 3 0.03 33.49 HELICOBACTER GASTRITIS | 3 0.03 33.52 HELICOBACTER INFECTION | 4 0.04 33.56 HEMIPARESIS | 1 0.01 33.57 HEPATIC CIRRHOSIS | 3 0.03 33.60 HEPATIC LESION | 1 0.01 33.61 HEPATIC NEOPLASM MALIGNANT | 35 0.35 33.96 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 1 0.01 33.97 HEPATIC NEOPLASM MALIGNANT RECURRENT | 1 0.01 33.98 HEPATITIS | 2 0.02 34.00 HEPATITIS B | 2 0.02 34.02 HEPATITIS C | 300 3.00 37.02 HEREDITARY ANGIOEDEMA | 2 0.02 37.04 HEREDITARY SPHEROCYTOSIS | 1 0.01 37.05 HERPES VIRUS INFECTION | 2 0.02 37.07 HERPES ZOSTER | 6 0.06 37.13 HIATUS HERNIA | 3 0.03 37.16 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 37.17 HIP ARTHROPLASTY | 8 0.08 37.25 HIP SURGERY | 2 0.02 37.27 HIRSUTISM | 1 0.01 37.28 HISTIOCYTOSIS HAEMATOPHAGIC | 10 0.10 37.38 HISTOPLASMOSIS | 16 0.16 37.54 HIV INFECTION | 49 0.49 38.03 HODGKIN'S DISEASE | 15 0.15 38.18 HORMONE LEVEL ABNORMAL | 1 0.01 38.19 HORMONE REPLACEMENT THERAPY | 16 0.16 38.35 HORMONE THERAPY | 5 0.05 38.40 HOT FLUSH | 3 0.03 38.43 HUMAN HERPESVIRUS 6 INFECTION | 1 0.01 38.44 HYPER IGD SYNDROME | 2 0.02 38.46 HYPERCALCAEMIA | 1 0.01 38.47 HYPERCHLORHYDRIA | 2 0.02 38.49 HYPERCHOLESTEROLAEMIA | 37 0.37 38.86 HYPERKALAEMIA | 1 0.01 38.87 HYPERLIPIDAEMIA | 28 0.28 39.15 HYPERPARATHYROIDISM | 1 0.01 39.16 HYPERPARATHYROIDISM SECONDARY | 4 0.04 39.20 HYPERPHOSPHATAEMIA | 6 0.06 39.26 HYPERSENSITIVITY | 25 0.25 39.51 HYPERSOMNIA | 6 0.06 39.57 HYPERTENSION | 357 3.57 43.14 HYPERTHYROIDISM | 3 0.03 43.17 HYPERTONIC BLADDER | 12 0.12 43.29 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 43.30 HYPERURICAEMIA | 8 0.08 43.38 HYPOALDOSTERONISM | 1 0.01 43.39 HYPOCALCAEMIA | 3 0.03 43.42 HYPOGLYCAEMIA | 2 0.02 43.44 HYPOGONADISM MALE | 3 0.03 43.47 HYPOKALAEMIA | 4 0.04 43.51 HYPOMAGNESAEMIA | 1 0.01 43.52 HYPOPHAGIA | 3 0.03 43.55 HYPOPHYSITIS | 1 0.01 43.56 HYPOPITUITARISM | 2 0.02 43.58 HYPOTENSION | 6 0.06 43.64 HYPOTHALAMO-PITUITARY DISORDER | 1 0.01 43.65 HYPOTHYROIDISM | 58 0.58 44.23 HYPOVITAMINOSIS | 1 0.01 44.24 HYPOVOLAEMIA | 1 0.01 44.25 HYPOXIA | 1 0.01 44.26 HYSTERECTOMY | 3 0.03 44.29 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 11 0.11 44.40 ILL-DEFINED DISORDER | 7 0.07 44.47 IMMUNISATION | 2 0.02 44.49 IMMUNOSUPPRESSANT DRUG THERAPY | 2 0.02 44.51 IMMUNOSUPPRESSION | 34 0.34 44.85 IMPAIRED GASTRIC EMPTYING | 1 0.01 44.86 IMPULSIVE BEHAVIOUR | 1 0.01 44.87 IN VITRO FERTILISATION | 2 0.02 44.89 INCONTINENCE | 3 0.03 44.92 INCREASED APPETITE | 1 0.01 44.93 INDUCTION OF ANAESTHESIA | 2 0.02 44.95 INFECTION | 16 0.16 45.11 INFECTION PROPHYLAXIS | 23 0.23 45.34 INFERTILITY | 3 0.03 45.37 INFLAMMATION | 9 0.09 45.46 INFLAMMATORY BOWEL DISEASE | 8 0.08 45.54 INFLUENZA | 3 0.03 45.57 INSOMNIA | 34 0.34 45.91 INSULIN-LIKE GROWTH FACTOR INCREASED | 1 0.01 45.92 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 4 0.04 45.96 INTERSTITIAL LUNG DISEASE | 2 0.02 45.98 INTERVERTEBRAL DISC PROTRUSION | 2 0.02 46.00 INTRAOCULAR PRESSURE INCREASED | 1 0.01 46.01 IRIDOCYCLITIS | 1 0.01 46.02 IRON DEFICIENCY | 1 0.01 46.03 IRON DEFICIENCY ANAEMIA | 2 0.02 46.05 IRON OVERLOAD | 7 0.07 46.12 IRRITABLE BOWEL SYNDROME | 8 0.08 46.20 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 46.21 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 3 0.03 46.24 ISCHAEMIC STROKE | 1 0.01 46.25 JOINT ARTHROPLASTY | 1 0.01 46.26 JOINT SWELLING | 3 0.03 46.29 JUVENILE ARTHRITIS | 5 0.05 46.34 KAPOSI'S SARCOMA | 1 0.01 46.35 KERATITIS | 2 0.02 46.37 KLEBSIELLA INFECTION | 1 0.01 46.38 KNEE ARTHROPLASTY | 15 0.15 46.53 KNEE OPERATION | 2 0.02 46.55 LARYNGITIS | 1 0.01 46.56 LARYNGITIS FUNGAL | 1 0.01 46.57 LATENT TUBERCULOSIS | 2 0.02 46.59 LAXATIVE SUPPORTIVE CARE | 1 0.01 46.60 LEIOMYOSARCOMA METASTATIC | 1 0.01 46.61 LEUKAEMIA | 1 0.01 46.62 LIBIDO INCREASED | 1 0.01 46.63 LIMB INJURY | 1 0.01 46.64 LIPID METABOLISM DISORDER | 2 0.02 46.66 LIPIDS ABNORMAL | 1 0.01 46.67 LIPODYSTROPHY ACQUIRED | 1 0.01 46.68 LIVER TRANSPLANT | 14 0.14 46.82 LOCAL ANAESTHESIA | 2 0.02 46.84 LOCALISED INFECTION | 1 0.01 46.85 LOSS OF CONSCIOUSNESS | 1 0.01 46.86 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 46.87 LOWER RESPIRATORY TRACT INFECTION | 4 0.04 46.91 LOWER URINARY TRACT SYMPTOMS | 1 0.01 46.92 LUNG ABSCESS | 7 0.07 46.99 LUNG ADENOCARCINOMA | 1 0.01 47.00 LUNG ADENOCARCINOMA STAGE IV | 3 0.03 47.03 LUNG CANCER METASTATIC | 1 0.01 47.04 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 8 0.08 47.12 LUNG DISORDER | 5 0.05 47.17 LUNG INFECTION | 1 0.01 47.18 LUNG NEOPLASM MALIGNANT | 23 0.23 47.41 LUNG SQUAMOUS CELL CARCINOMA STAGE III | 1 0.01 47.42 LUNG TRANSPLANT | 3 0.03 47.45 LYME DISEASE | 1 0.01 47.46 LYMPHOMA | 5 0.05 47.51 MACULAR DEGENERATION | 2 0.02 47.53 MACULOPATHY | 1 0.01 47.54 MAJOR DEPRESSION | 4 0.04 47.58 MALAISE | 1 0.01 47.59 MALARIA | 2 0.02 47.61 MALIGNANT FIBROUS HISTIOCYTOMA | 2 0.02 47.63 MALIGNANT GLIOMA | 2 0.02 47.65 MALIGNANT MELANOMA | 11 0.11 47.76 MALIGNANT RESPIRATORY TRACT NEOPLASM | 1 0.01 47.77 MALIGNANT URINARY TRACT NEOPLASM | 2 0.02 47.79 MANTLE CELL LYMPHOMA | 3 0.03 47.82 MATERNAL EXPOSURE DURING PREGNANCY | 5 0.05 47.87 MATERNAL EXPOSURE TIMING UNSPECIFIED | 9 0.09 47.96 MEDICAL DIET | 11 0.11 48.07 MEMORY IMPAIRMENT | 2 0.02 48.09 MENINGITIS | 3 0.03 48.12 MENISCUS LESION | 1 0.01 48.13 MENOPAUSAL SYMPTOMS | 3 0.03 48.16 MENOPAUSE | 6 0.06 48.22 MENORRHAGIA | 11 0.11 48.33 MENSTRUAL CYCLE MANAGEMENT | 4 0.04 48.37 MENSTRUAL DISCOMFORT | 1 0.01 48.38 MENSTRUAL DISORDER | 1 0.01 48.39 MENSTRUATION IRREGULAR | 2 0.02 48.41 MENTAL DISORDER | 20 0.20 48.61 MENTAL IMPAIRMENT | 1 0.01 48.62 MENTAL STATUS CHANGES | 1 0.01 48.63 MERALGIA PARAESTHETICA | 1 0.01 48.64 METABOLIC DISORDER | 1 0.01 48.65 METASTASES TO BONE | 31 0.31 48.96 METASTASES TO LUNG | 1 0.01 48.97 METASTASES TO PELVIS | 1 0.01 48.98 METASTASES TO PLEURA | 3 0.03 49.01 METASTASIS | 1 0.01 49.02 METASTATIC GASTRIC CANCER | 4 0.04 49.06 METASTATIC MALIGNANT MELANOMA | 3 0.03 49.09 METASTATIC NEOPLASM | 1 0.01 49.10 METASTATIC PAIN | 3 0.03 49.13 METASTATIC RENAL CELL CARCINOMA | 35 0.35 49.48 MEVALONATE KINASE DEFICIENCY | 3 0.03 49.51 MICTURITION URGENCY | 1 0.01 49.52 MIGRAINE | 40 0.40 49.92 MIGRAINE PROPHYLAXIS | 2 0.02 49.94 MINERAL SUPPLEMENTATION | 8 0.08 50.02 MONONUCLEOSIS SYNDROME | 1 0.01 50.03 MOOD ALTERED | 1 0.01 50.04 MOOD SWINGS | 2 0.02 50.06 MORTON'S NEUROMA | 1 0.01 50.07 MUCOPOLYSACCHARIDOSIS II | 1 0.01 50.08 MUCOSAL INFLAMMATION | 3 0.03 50.11 MUCOUS MEMBRANE DISORDER | 2 0.02 50.13 MULTIPLE ALLERGIES | 5 0.05 50.18 MULTIPLE MYELOMA | 81 0.81 50.99 MULTIPLE SCLEROSIS | 486 4.86 55.85 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 55.87 MUSCLE DISORDER | 1 0.01 55.88 MUSCLE RELAXANT THERAPY | 5 0.05 55.93 MUSCLE SPASMS | 21 0.21 56.14 MUSCLE SPASTICITY | 4 0.04 56.18 MUSCULOSKELETAL CHEST PAIN | 2 0.02 56.20 MUSCULOSKELETAL PAIN | 8 0.08 56.28 MUSCULOSKELETAL STIFFNESS | 2 0.02 56.30 MYALGIA | 1 0.01 56.31 MYELODYSPLASTIC SYNDROME | 8 0.08 56.39 MYELOFIBROSIS | 9 0.09 56.48 MYELOID METAPLASIA | 2 0.02 56.50 MYELOMA RECURRENCE | 1 0.01 56.51 MYELOPATHY | 2 0.02 56.53 MYOCARDIAL INFARCTION | 8 0.08 56.61 MYOCARDIAL ISCHAEMIA | 16 0.16 56.77 NARCOLEPSY | 25 0.25 57.02 NASAL CONGESTION | 2 0.02 57.04 NASOPHARYNGITIS | 5 0.05 57.09 NAUSEA | 28 0.28 57.37 NECK PAIN | 7 0.07 57.44 NEONATAL RESPIRATORY DISTRESS SYNDROME | 1 0.01 57.45 NEOPLASM | 1 0.01 57.46 NEOPLASM MALIGNANT | 2 0.02 57.48 NEPHRECTOMY | 1 0.01 57.49 NEPHROGENIC ANAEMIA | 3 0.03 57.52 NEPHROTIC SYNDROME | 1 0.01 57.53 NERVE INJURY | 3 0.03 57.56 NERVOUSNESS | 2 0.02 57.58 NEURALGIA | 14 0.14 57.72 NEUROENDOCRINE TUMOUR | 12 0.12 57.84 NEUROLOGICAL SYMPTOM | 1 0.01 57.85 NEUROPATHY PERIPHERAL | 14 0.14 57.99 NEUTROPENIA | 1 0.01 58.00 NIEMANN-PICK DISEASE | 2 0.02 58.02 NIGHT BLINDNESS | 1 0.01 58.03 NIGHT SWEATS | 1 0.01 58.04 NON-HODGKIN'S LYMPHOMA | 23 0.23 58.27 NON-SMALL CELL LUNG CANCER | 23 0.23 58.50 NON-SMALL CELL LUNG CANCER METASTATIC | 1 0.01 58.51 NON-SMALL CELL LUNG CANCER STAGE IIIA | 12 0.12 58.63 NON-SMALL CELL LUNG CANCER STAGE IIIB | 33 0.33 58.96 NON-SMALL CELL LUNG CANCER STAGE IV | 2 0.02 58.98 NUCLEAR MAGNETIC RESONANCE IMAGING | 4 0.04 59.02 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 59.03 NUTRITIONAL SUPPORT | 6 0.06 59.09 OBESITY | 2 0.02 59.11 OBSESSIVE-COMPULSIVE DISORDER | 1 0.01 59.12 OCULAR HYPERTENSION | 5 0.05 59.17 OCULAR PEMPHIGOID | 3 0.03 59.20 ODYNOPHAGIA | 1 0.01 59.21 OEDEMA | 6 0.06 59.27 OEDEMA PERIPHERAL | 5 0.05 59.32 OESOPHAGEAL CANDIDIASIS | 1 0.01 59.33 OESOPHAGEAL CARCINOMA | 1 0.01 59.34 OESOPHAGEAL DISORDER | 2 0.02 59.36 OESOPHAGEAL ULCER | 1 0.01 59.37 OESTROGEN THERAPY | 1 0.01 59.38 OFF LABEL USE | 4 0.04 59.42 ONYCHOMYCOSIS | 1 0.01 59.43 OOPHORECTOMY | 1 0.01 59.44 OPEN ANGLE GLAUCOMA | 1 0.01 59.45 ORAL CONTRACEPTION | 6 0.06 59.51 ORAL PAIN | 1 0.01 59.52 ORAL SURGERY | 1 0.01 59.53 OROPHARYNGEAL PAIN | 2 0.02 59.55 ORTHOPEDIC PROCEDURE | 3 0.03 59.58 OSTEOARTHRITIS | 12 0.12 59.70 OSTEOMYELITIS | 3 0.03 59.73 OSTEOMYELITIS FUNGAL | 2 0.02 59.75 OSTEONECROSIS | 3 0.03 59.78 OSTEOPENIA | 163 1.63 61.41 OSTEOPOROSIS | 354 3.54 64.95 OSTEOPOROSIS POSTMENOPAUSAL | 9 0.09 65.04 OSTEOPOROSIS PROPHYLAXIS | 25 0.25 65.29 OSTEOPOROTIC FRACTURE | 1 0.01 65.30 OVARIAN CANCER | 14 0.14 65.44 OVARIAN CANCER RECURRENT | 1 0.01 65.45 OVARIAN CYST | 1 0.01 65.46 OVARIAN EPITHELIAL CANCER | 8 0.08 65.54 OVULATION INDUCTION | 1 0.01 65.55 PAIN | 198 1.98 67.53 PAIN IN EXTREMITY | 15 0.15 67.68 PAIN MANAGEMENT | 7 0.07 67.75 PAIN PROPHYLAXIS | 1 0.01 67.76 PALPITATIONS | 2 0.02 67.78 PANCREAS TRANSPLANT | 1 0.01 67.79 PANCREATIC CARCINOMA | 10 0.10 67.89 PANCREATIC CARCINOMA METASTATIC | 2 0.02 67.91 PANCREATIC CARCINOMA STAGE IV | 2 0.02 67.93 PANCREATIC INSUFFICIENCY | 1 0.01 67.94 PANCREATIC NEUROENDOCRINE TUMOUR | 2 0.02 67.96 PANCREATIC NEUROENDOCRINE TUMOUR META.. | 1 0.01 67.97 PANCREATITIS CHRONIC | 1 0.01 67.98 PANCYTOPENIA | 1 0.01 67.99 PANIC ATTACK | 7 0.07 68.06 PANIC DISORDER | 1 0.01 68.07 PAPILLOMA VIRAL INFECTION | 2 0.02 68.09 PARACENTESIS | 1 0.01 68.10 PARACOCCIDIOIDES INFECTION | 2 0.02 68.12 PARAESTHESIA | 1 0.01 68.13 PARANOIA | 1 0.01 68.14 PARKINSON'S DISEASE | 13 0.13 68.27 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 1 0.01 68.28 PARTIAL SEIZURES | 1 0.01 68.29 PELVIC PAIN | 1 0.01 68.30 PELVIC PROLAPSE | 1 0.01 68.31 PENILE VASCULAR DISORDER | 1 0.01 68.32 PEPTIC ULCER | 1 0.01 68.33 PERCUTANEOUS CORONARY INTERVENTION | 1 0.01 68.34 PERICARDIAL MESOTHELIOMA MALIGNANT AD.. | 2 0.02 68.36 PERIODONTITIS | 2 0.02 68.38 PERIOPERATIVE ANALGESIA | 2 0.02 68.40 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED | 6 0.06 68.46 PERIPHERAL VASCULAR DISORDER | 1 0.01 68.47 PERITONEAL DIALYSIS | 74 0.74 69.21 PERITONITIS | 1 0.01 69.22 PERNICIOUS ANAEMIA | 1 0.01 69.23 PERSONALITY DISORDER | 1 0.01 69.24 PHARYNGEAL INFLAMMATION | 1 0.01 69.25 PHARYNGITIS BACTERIAL | 1 0.01 69.26 PHARYNGITIS STREPTOCOCCAL | 1 0.01 69.27 PHENYLKETONURIA | 2 0.02 69.29 PHOTODERMATOSIS | 1 0.01 69.30 PHYLLODES TUMOUR | 2 0.02 69.32 PIGMENTATION DISORDER | 1 0.01 69.33 PIRIFORMIS SYNDROME | 1 0.01 69.34 PITUITARY TUMOUR BENIGN | 1 0.01 69.35 PLASMACYTOMA | 1 0.01 69.36 PLATELET AGGREGATION INHIBITION | 1 0.01 69.37 PLATELET DISORDER | 2 0.02 69.39 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 69.43 PNEUMONIA | 11 0.11 69.54 PNEUMONIA ASPIRATION | 3 0.03 69.57 PNEUMONIA PRIMARY ATYPICAL | 2 0.02 69.59 PNEUMONITIS | 3 0.03 69.62 PNEUMOTHORAX | 2 0.02 69.64 POLLAKIURIA | 2 0.02 69.66 POLYARTHRITIS | 5 0.05 69.71 POLYCYSTIC OVARIES | 4 0.04 69.75 POLYMYALGIA RHEUMATICA | 2 0.02 69.77 POLYURIA | 4 0.04 69.81 POOR PERIPHERAL CIRCULATION | 1 0.01 69.82 PORTOPULMONARY HYPERTENSION | 1 0.01 69.83 POST COITAL CONTRACEPTION | 39 0.39 70.22 POST HERPETIC NEURALGIA | 2 0.02 70.24 POST POLIO SYNDROME | 2 0.02 70.26 POST PROCEDURAL INFECTION | 1 0.01 70.27 POST-TRAUMATIC EPILEPSY | 1 0.01 70.28 POST-TRAUMATIC STRESS DISORDER | 12 0.12 70.40 POSTMENOPAUSE | 2 0.02 70.42 POSTPARTUM DEPRESSION | 1 0.01 70.43 PREGNANCY | 8 0.08 70.51 PREMATURE BABY | 3 0.03 70.54 PREMEDICATION | 50 0.50 71.04 PREMENSTRUAL SYNDROME | 32 0.32 71.36 PRINZMETAL ANGINA | 1 0.01 71.37 PROCEDURAL PAIN | 1 0.01 71.38 PRODUCT USED FOR UNKNOWN INDICATION | 1,023 10.23 81.61 PROGRESSIVE RELAPSING MULTIPLE SCLERO.. | 2 0.02 81.63 PROLACTINOMA | 1 0.01 81.64 PROPHYLAXIS | 121 1.21 82.85 PROPHYLAXIS AGAINST DIARRHOEA | 5 0.05 82.90 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 14 0.14 83.04 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 25 0.25 83.29 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 4 0.04 83.33 PROPHYLAXIS OF NAUSEA AND VOMITING | 7 0.07 83.40 PROPHYLAXIS URINARY TRACT INFECTION | 3 0.03 83.43 PROSTATE CANCER | 20 0.20 83.63 PROSTATE CANCER METASTATIC | 24 0.24 83.87 PROSTATIC DISORDER | 4 0.04 83.91 PROSTATITIS | 1 0.01 83.92 PROSTATOMEGALY | 1 0.01 83.93 PROTEINURIA | 1 0.01 83.94 PRURITUS | 12 0.12 84.06 PSEUDOMONAS INFECTION | 1 0.01 84.07 PSOAS ABSCESS | 3 0.03 84.10 PSORIASIS | 51 0.51 84.61 PSORIATIC ARTHROPATHY | 26 0.26 84.87 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 84.88 PSYCHOTIC DISORDER | 12 0.12 85.00 PULMONARY ARTERIAL HYPERTENSION | 105 1.05 86.05 PULMONARY EMBOLISM | 8 0.08 86.13 PULMONARY HYPERTENSION | 24 0.24 86.37 PULMONARY THROMBOSIS | 1 0.01 86.38 PULMONARY TUBERCULOSIS | 12 0.12 86.50 PURULENCE | 1 0.01 86.51 PUSTULAR PSORIASIS | 2 0.02 86.53 PYODERMA GANGRENOSUM | 3 0.03 86.56 PYREXIA | 15 0.15 86.71 RASH | 3 0.03 86.74 RECTAL CANCER | 4 0.04 86.78 REFLUX GASTRITIS | 3 0.03 86.81 REFRACTORY ANAEMIA WITH AN EXCESS OF .. | 1 0.01 86.82 REGIONAL CHEMOTHERAPY | 2 0.02 86.84 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 49 0.49 87.33 RENAL CANCER | 18 0.18 87.51 RENAL CANCER METASTATIC | 4 0.04 87.55 RENAL CANCER STAGE IV | 1 0.01 87.56 RENAL CELL CARCINOMA | 20 0.20 87.76 RENAL DISORDER | 3 0.03 87.79 RENAL FAILURE | 4 0.04 87.83 RENAL FAILURE ACUTE | 1 0.01 87.84 RENAL FAILURE CHRONIC | 11 0.11 87.95 RENAL IMPAIRMENT | 1 0.01 87.96 RENAL TRANSPLANT | 22 0.22 88.18 RESPIRATORY DISORDER | 5 0.05 88.23 RESPIRATORY FAILURE | 3 0.03 88.26 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 88.27 RESPIRATORY TRACT CONGESTION | 2 0.02 88.29 RESPIRATORY TRACT INFECTION | 2 0.02 88.31 RESTLESS LEGS SYNDROME | 13 0.13 88.44 RESTLESSNESS | 2 0.02 88.46 RHABDOMYOSARCOMA | 2 0.02 88.48 RHEUMATOID ARTHRITIS | 272 2.72 91.20 RHINITIS | 2 0.02 91.22 RHINITIS ALLERGIC | 11 0.11 91.33 ROSACEA | 3 0.03 91.36 ROTATOR CUFF SYNDROME | 2 0.02 91.38 ROUTINE HEALTH MAINTENANCE | 19 0.19 91.57 SALIVARY HYPERSECRETION | 5 0.05 91.62 SARCOIDOSIS | 5 0.05 91.67 SARCOMA | 2 0.02 91.69 SARCOMA METASTATIC | 6 0.06 91.75 SCAN BRAIN | 1 0.01 91.76 SCAN MYOCARDIAL PERFUSION | 3 0.03 91.79 SCHIZOAFFECTIVE DISORDER | 10 0.10 91.89 SCHIZOID PERSONALITY DISORDER | 1 0.01 91.90 SCHIZOPHRENIA | 66 0.66 92.56 SCHIZOPHRENIA, PARANOID TYPE | 8 0.08 92.64 SCIATICA | 4 0.04 92.68 SCLERODERMA | 2 0.02 92.70 SCOLIOSIS | 3 0.03 92.73 SEASONAL ALLERGY | 7 0.07 92.80 SEBORRHOEIC DERMATITIS | 1 0.01 92.81 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 92.82 SECRETION DISCHARGE | 1 0.01 92.83 SEDATION | 17 0.17 93.00 SENILE OSTEOPOROSIS | 1 0.01 93.01 SEPSIS | 5 0.05 93.06 SERONEGATIVE ARTHRITIS | 1 0.01 93.07 SHORT-BOWEL SYNDROME | 6 0.06 93.13 SICKLE CELL ANAEMIA | 3 0.03 93.16 SILVER-RUSSELL SYNDROME | 1 0.01 93.17 SINUS DISORDER | 3 0.03 93.20 SINUS TACHYCARDIA | 1 0.01 93.21 SINUSITIS | 7 0.07 93.28 SJOGREN'S SYNDROME | 1 0.01 93.29 SKIN REACTION | 1 0.01 93.30 SKIN WRINKLING | 1 0.01 93.31 SLEEP APNOEA SYNDROME | 35 0.35 93.66 SLEEP DISORDER | 43 0.43 94.09 SLEEP DISORDER THERAPY | 2 0.02 94.11 SMALL CELL CARCINOMA | 2 0.02 94.13 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 2 0.02 94.15 SMALL FOR DATES BABY | 1 0.01 94.16 SMOKING CESSATION THERAPY | 61 0.61 94.77 SNEEZING | 1 0.01 94.78 SOCIAL PHOBIA | 1 0.01 94.79 SOMATIC DELUSION | 2 0.02 94.81 SOMNOLENCE | 9 0.09 94.90 SPINAL ANAESTHESIA | 4 0.04 94.94 SPINAL COLUMN STENOSIS | 1 0.01 94.95 SPINAL COMPRESSION FRACTURE | 1 0.01 94.96 SPINAL DISORDER | 2 0.02 94.98 SPINAL FUSION SURGERY | 1 0.01 94.99 SPINAL LIGAMENT OSSIFICATION | 1 0.01 95.00 SPINAL MYELOGRAM | 1 0.01 95.01 SPINAL PAIN | 3 0.03 95.04 SPONDYLITIS | 1 0.01 95.05 SPONDYLOARTHROPATHY | 2 0.02 95.07 SQUAMOUS CELL CARCINOMA | 9 0.09 95.16 STAPHYLOCOCCAL INFECTION | 3 0.03 95.19 STATUS EPILEPTICUS | 3 0.03 95.22 STEM CELL TRANSPLANT | 5 0.05 95.27 STENT PLACEMENT | 3 0.03 95.30 STEROID THERAPY | 1 0.01 95.31 STEVENS-JOHNSON SYNDROME | 1 0.01 95.32 STILL'S DISEASE ADULT ONSET | 1 0.01 95.33 STOMATITIS | 2 0.02 95.35 STREPTOCOCCAL INFECTION | 1 0.01 95.36 STRESS | 5 0.05 95.41 SUBCUTANEOUS ABSCESS | 2 0.02 95.43 SUBILEUS | 1 0.01 95.44 SUICIDE ATTEMPT | 5 0.05 95.49 SUPPLEMENTATION THERAPY | 33 0.33 95.82 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 95.85 SURGERY | 1 0.01 95.86 SWELLING | 5 0.05 95.91 SYSTEMIC LUPUS ERYTHEMATOSUS | 3 0.03 95.94 TACHYARRHYTHMIA | 10 0.10 96.04 TACHYCARDIA | 2 0.02 96.06 TEETHING | 1 0.01 96.07 TEMPORAL ARTERITIS | 2 0.02 96.09 TENDONITIS | 2 0.02 96.11 TENSION HEADACHE | 1 0.01 96.12 TESTICULAR GERM CELL CANCER | 3 0.03 96.15 THERAPEUTIC PROCEDURE | 2 0.02 96.17 THERAPY CESSATION | 4 0.04 96.21 THORACIC CAVITY DRAINAGE | 1 0.01 96.22 THROMBOCYTOPENIA | 1 0.01 96.23 THROMBOCYTOSIS | 3 0.03 96.26 THROMBOPHLEBITIS | 3 0.03 96.29 THROMBOSIS | 5 0.05 96.34 THROMBOSIS PROPHYLAXIS | 50 0.50 96.84 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 96.86 THYROID CANCER | 5 0.05 96.91 THYROID DISORDER | 24 0.24 97.15 THYROID FUNCTION TEST ABNORMAL | 1 0.01 97.16 THYROID HORMONE REPLACEMENT THERAPY | 1 0.01 97.17 THYROIDECTOMY | 3 0.03 97.20 TOBACCO USER | 2 0.02 97.22 TONGUE CANCER METASTATIC | 3 0.03 97.25 TONSILLITIS | 2 0.02 97.27 TONSILLITIS BACTERIAL | 1 0.01 97.28 TOOTH DISORDER | 1 0.01 97.29 TOOTH INFECTION | 1 0.01 97.30 TOOTHACHE | 2 0.02 97.32 TORTICOLLIS | 2 0.02 97.34 TOXIC EPIDERMAL NECROLYSIS | 1 0.01 97.35 TRANSIENT ISCHAEMIC ATTACK | 1 0.01 97.36 TREMOR | 6 0.06 97.42 TRIGEMINAL NERVE DISORDER | 1 0.01 97.43 TRIGEMINAL NEURALGIA | 6 0.06 97.49 TRIGGER FINGER | 2 0.02 97.51 TUBERCULIN TEST | 1 0.01 97.52 TUBERCULOSIS | 10 0.10 97.62 TUBEROUS SCLEROSIS | 1 0.01 97.63 TUMOUR LYSIS SYNDROME | 1 0.01 97.64 TYPE 1 DIABETES MELLITUS | 11 0.11 97.75 TYPE 2 DIABETES MELLITUS | 86 0.86 98.61 TYPE IIA HYPERLIPIDAEMIA | 2 0.02 98.63 ULCER | 3 0.03 98.66 UNDERWEIGHT | 1 0.01 98.67 UNEVALUABLE EVENT | 4 0.04 98.71 UNRELATED DONOR BONE MARROW TRANSPLAN.. | 1 0.01 98.72 UPPER LIMB FRACTURE | 1 0.01 98.73 UPPER RESPIRATORY TRACT INFECTION | 4 0.04 98.77 UPPER-AIRWAY COUGH SYNDROME | 1 0.01 98.78 URINARY INCONTINENCE | 5 0.05 98.83 URINARY TRACT DISORDER | 2 0.02 98.85 URINARY TRACT INFECTION | 19 0.19 99.04 URINE FLOW DECREASED | 1 0.01 99.05 URINE OUTPUT DECREASED | 1 0.01 99.06 URTICARIA | 2 0.02 99.08 UVEITIS | 2 0.02 99.10 VAGINAL DISORDER | 1 0.01 99.11 VARICELLA | 1 0.01 99.12 VASCULITIS | 3 0.03 99.15 VENOUS INSUFFICIENCY | 1 0.01 99.16 VENOUS PRESSURE ABNORMAL | 9 0.09 99.25 VENTRICULAR FIBRILLATION | 1 0.01 99.26 VERTIGO | 3 0.03 99.29 VIITH NERVE PARALYSIS | 1 0.01 99.30 VISCERAL LEISHMANIASIS | 13 0.13 99.43 VITAMIN B COMPLEX DEFICIENCY | 3 0.03 99.46 VITAMIN D DECREASED | 2 0.02 99.48 VITAMIN D DEFICIENCY | 2 0.02 99.50 VITAMIN SUPPLEMENTATION | 21 0.21 99.71 VITILIGO | 1 0.01 99.72 VOMITING | 8 0.08 99.80 VOMITING IN PREGNANCY | 1 0.01 99.81 VULVOVAGINAL CANDIDIASIS | 1 0.01 99.82 VULVOVAGINAL DISCOMFORT | 1 0.01 99.83 VULVOVAGINAL DRYNESS | 2 0.02 99.85 VULVOVAGINAL MYCOTIC INFECTION | 2 0.02 99.87 WEGENER'S GRANULOMATOSIS | 2 0.02 99.89 WEIGHT CONTROL | 1 0.01 99.90 WEIGHT DECREASED | 1 0.01 99.91 WHEEZING | 4 0.04 99.95 WOUND INFECTION | 4 0.04 99.99 WOUND TREATMENT | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015